导致双重葡萄糖失调的SUR1突变的分子和功能特征
Davoud Amirkashani1, P V Migisha Ntwali2, Behnoosh Tasharrofi3
1Division of Endocrinology and Metabolism, Ali-Asghar Children Hospital, Iran University of Medical Sciences, Tehran, 1449614535, Iran.
研究人员在糖尿病患者中研究了SUR1 Y123F变体,发现它改变了对ATP敏感的通道活性. 这可能解释高血糖症,但需要进一步的研究来了解低血糖症.
科学领域:
- 遗传学和分子生物学
- 生物化学 生物化学
- 计算生物学 计算生物学
背景情况:
- 一名患者出现了交替的糖尿病酸症 (DKA) 和失糖症,包括高血糖症和饭后低血糖症.
- 全外体测序 (WES) 在受影响患者中发现了一种新的SUR1误解变异Y123F.
研究的目的:
- 进行SUR1 Y123F变种的分子和功能表征.
- 通过一种集成的in silico实验方法来阐明这种糖尿病相关突变的致病机制.
主要方法:
- 在分析包括进化分析,结构意识和基于能量的预测,以及分子动力学模拟 (MDS).
- 实验验证涉及免疫注射以评估蛋白质丰富度和Rb+流量测试以测量通道活性.
- 复制的SUR1-Kir6.2复合物的功能评估.
主要成果:
- 在分析中预测,Y123F替代稍微破坏了SUR1的稳定,减少了与Kir6.2的接口接触,增加了局部灵活性,并改变了自由能源景观.
- 在实验中,突变SUR1显示稳定状态丰度降低,重组的SUR1-Kir6.2复合体表现出增强的ATP敏感 (KATP) 通道封锁活性 (增加Rb+流量).
- 建议增强的KATP通道活性有助于患者的高血糖.
结论:
- SUR1 Y123F变体改变了SUR1-Kir6.2的相互作用,导致KATP通道活性增加,可能解释高血糖症.
- 餐后低血糖症表明复杂的生理调节并未完全被体外研究所捕捉,需要进一步的体内调查.
- 一个集成在的实验管道对于评估与疾病相关的变体和为糖尿病治疗策略提供信息是有价值的.
更多相关视频
11:49A Novel Saturation Mutagenesis Approach: Single Step Characterization of Regulatory Protein Binding Sites in RNA Using Phosphorothioates
Published on: August 21, 2018
07:55A Deep-sequencing-assisted, Spontaneous Suppressor Screen in the Fission Yeast Schizosaccharomyces pombe
Published on: March 7, 2019
相关概念视频
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Absorption Into the Small Intestine
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Oral Hypoglycemic Agents: Sulfonylureas
